T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 56 filers reported holding T2 BIOSYSTEMS INC in Q3 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 19,668 | -5.5% | 0.00% | – |
Q2 2022 | $3,000 | -50.0% | 20,818 | +85.6% | 0.00% | – |
Q1 2022 | $6,000 | +20.0% | 11,214 | +11.4% | 0.00% | – |
Q4 2021 | $5,000 | -86.1% | 10,064 | -74.7% | 0.00% | – |
Q3 2021 | $36,000 | -21.7% | 39,764 | +2.1% | 0.00% | – |
Q2 2021 | $46,000 | +17.9% | 38,964 | +60.8% | 0.00% | – |
Q1 2021 | $39,000 | +56.0% | 24,234 | +21.6% | 0.00% | – |
Q4 2020 | $25,000 | +31.6% | 19,934 | +40.4% | 0.00% | – |
Q3 2020 | $19,000 | +5.6% | 14,200 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | -25.0% | 14,200 | -62.2% | 0.00% | – |
Q1 2020 | $24,000 | +50.0% | 37,600 | +168.6% | 0.00% | – |
Q4 2019 | $16,000 | -62.8% | 14,000 | -17.6% | 0.00% | – |
Q3 2019 | $43,000 | +38.7% | 17,000 | +11.8% | 0.00% | – |
Q1 2019 | $31,000 | -46.6% | 15,200 | -20.8% | 0.00% | – |
Q4 2018 | $58,000 | -48.2% | 19,200 | +28.0% | 0.00% | – |
Q3 2018 | $112,000 | +1144.4% | 15,000 | +782.4% | 0.00% | – |
Q4 2016 | $9,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 2,374,571 | $36,853,000 | 16.46% |
Aisling Capital LLC | 2,523,300 | $39,162,000 | 5.12% |
AlpInvest Partners B.V. | 134,087 | $2,081,000 | 3.89% |
Foresite Capital Management II, LLC | 233,019 | $3,616,000 | 2.14% |
Senvest Management, LLC | 511,366 | $7,936,000 | 0.49% |
Harvest Capital Strategies LLC | 356,900 | $5,539,000 | 0.49% |
HAMILTON LANE ADVISORS LLC | 64,226 | $997,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 148,027 | $2,297,000 | 0.32% |
GILDER GAGNON HOWE & CO LLC | 1,331,826 | $20,670,000 | 0.29% |
TIGER MANAGEMENT L.L.C. | 90,909 | $1,411,000 | 0.24% |